Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin.
about
Resveratrol alleviates endotoxin-induced myocardial toxicity via the Nrf2 transcription factorCardiac remodeling in obesity.Interleukin-1β reduces L-type Ca2+ current through protein kinase Cϵ activation in mouse heart.Association of the degree of adiposity and duration of obesity with measures of cardiac structure and function: the CARDIA studyA newly designed curcumin analog Y20 mitigates cardiac injury via anti-inflammatory and anti-oxidant actions in obese rats.Immune modulation therapy in heart failure.Bedside-Friendly Prediction for Presence of Post-Myocardial lnfarction Systolic Dysfunction Using Multimarker Panel: Integrating Salivary Diagnostics into Clinical PracticeIL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.Targets for immunomodulation in cardiovascular disease--where are we now?Oxidative stress and inflammatory markers - the future of heart failure diagnostics?Periodontitis and myocardial hypertrophy.Pulmonary venous hypertension and mechanical strain stimulate monocyte chemoattractant protein-1 release and structural remodelling of the lung in human and rodent chronic heart failure models.Fruit vinegars attenuate cardiac injury via anti-inflammatory and anti-adiposity actions in high-fat diet-induced obese rats.Sulforaphane, a Natural Isothiocyanate Compound, Improves Cardiac Function and Remodeling by Inhibiting Oxidative Stress and Inflammation in a Rabbit Model of Chronic Heart Failure.Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure.
P2860
Q28534757-E81AAD0A-30BB-49F6-8F1C-63D5DA6B2237Q34043589-30E50D27-0AD9-4B80-95BF-AAD4729B32F6Q34070335-7F6539C1-96AA-46D1-8012-E81F3D1B9A47Q34475431-085EE556-2D05-4EB1-A47F-1FB5E6DF891FQ35580597-BC2EAEB6-3283-473F-93F5-9CA812AF8DC9Q36440971-BCCE0ED1-DA89-443A-8885-D94F72DBFFE7Q36844342-6FDE7033-C455-45BD-97EE-D0CF6279C258Q37415365-D2FBD9B3-BAEB-4EFC-9270-70F5EFE05393Q37608525-AB51FB34-7626-46F7-A93E-F9B2CEC54DAAQ38967724-5C195ACC-7A2F-424A-BF4F-4414E2920EB7Q39004036-BC93A57E-F95D-4C06-90C9-87937BF129ACQ45868599-24FB2F48-3A8B-4BD5-BCE5-1D090D5CF554Q46335902-C0471C79-CEEF-4B41-BACC-028DBC36EB07Q52661832-766432D7-D8BC-45C0-8572-310B71265F34Q55363616-A1CA5F7B-40CB-4E1F-A3F4-89DBEC112292
P2860
Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inflammation and chronic heart ...... of intravenous immunoglobulin.
@ast
Inflammation and chronic heart ...... of intravenous immunoglobulin.
@en
type
label
Inflammation and chronic heart ...... of intravenous immunoglobulin.
@ast
Inflammation and chronic heart ...... of intravenous immunoglobulin.
@en
prefLabel
Inflammation and chronic heart ...... of intravenous immunoglobulin.
@ast
Inflammation and chronic heart ...... of intravenous immunoglobulin.
@en
P50
P1433
P1476
Inflammation and chronic heart ...... of intravenous immunoglobulin.
@en
P304
P356
10.1016/S1568-9972(03)00103-4
P577
2004-03-01T00:00:00Z